Traphaco fares poorly in optimising profit through financial tools

Traphaco fares poorly in optimising profit through financial tools

One of the major pharmaceutical firms in the country, Traphaco JSC seems to haveĀ forgotten the strength of financial vehicles for profit optimisation.
Competition intensifies in pharmaceutical sector

Competition intensifies in pharmaceutical sector

After a tough 12 months, competition in Vietnamā€™s lucrative pharmaceutical industry is forecast to heat up in 2019..
Foreign shareholders nominated for Traphaco management board

Foreign shareholders nominated for Traphaco management board

Super Delta Pte., Ltd. and Magbi Fund Limited want to add two Koreans to the board of directors of Traphaco.
Traphaco and Cadivi fined for tax arrears

Traphaco and Cadivi fined for tax arrears

Hanoi has just issued a fine of nearly $44,000 to Traphaco and $242,300 to Cadivi for erroneous tax declaration.
Traphaco just the right medicine for the market

Traphaco just the right medicine for the market

Traphaco has grown into the second largest pharmaceutical firm in Vietnam with a sharp network expansion and core business strategy.
VAF confidently looks to 2011

VAF confidently looks to 2011

The investment environment is likely to favour equity investment funds in blue chip companies. Chris Freund, managing partner of Mekong Capital, tells VIR about the investment opportunities of its Vietnam Azalea Fund (VAF) in 2011.
1 2